This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Net Medical Xpress Solutions Notes Congressional Proposal To Broaden Telemedicine Reimbursement

ALBUQUERQUE, N.M., Jan. 8, 2013 /PRNewswire/ -- Net Medical Xpress Solutions, Inc. (OTC Bulletin Board NMXC), said today that a Congressional proposal to increase telemedicine reimbursement could have a positive impact on the company's operations even as it contributes to lowering the country's healthcare costs.

The Telehealth Promotion Act of 2012 (H.R. 6719) sponsored by Congressman Mike Thompson would establish a federal reimbursement policy to ensure that no medical benefits are excluded as a result of being furnished by a telecommunications system. If passed, the bill is expected to increase access to telemedicine within Medicare, Medicaid, the Children's Health Insurance Program, TRICARE, federal employee health plans and the Department of Veterans Affairs.

CEO and President, Dick Govatski, said, "This proposed legislation underscores the growing acceptability of telemedicine as a key component of our health care system. The use of our telemedicine programs is already helping to lower health care costs here in New Mexico and this can easily be expanded nationwide. Among other advantages are incentivizing hospitals to lower readmissions by offering them a share of the total cost savings. Other benefits are allowing the medical community to use telemedicine as an equivalent substitute for in-person care and the use of remote monitoring to also help lower costs. We agree with those who say that passage of this legislation will almost instantly make our Federally-funded health care system more effective and more efficient."

About Net Medical Xpress Solutions, Inc:Net Medical Xpress' Telemedicine programs provide diagnostic and clinical medical services to mobile companies, urgent cares, hospitals, trauma centers, imaging centers, jails, nursing homes, corporate health departments, and out patient medical facilities.  The company's proprietary, web-based XR-Express 510K FDA cleared PACS is Net Medical Xpress foundation software, which enables medical providers to make real-time assessments of patients' conditions and treatment needs.

For more information, visit or or contact Dick Govatski, president and CEO, at 505-255-1999 or

An investment profile for Net Medical Xpress is at To receive future releases in e-mail alerts, sign up at

For more investor-related questions contact Frank Hawkins, Hawk Associates, at 305-451-1888 or Dick Govatski at 505-255-1999 (

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's Forms 10-K and 10-Q filed with the SEC.


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs